Clinical Trial Update: New Generation Drug Eluting Stent for In-stent Restenosis of Drug Eluting Stent( RESTENT-ISR Trial ) [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating a new generation drug-eluting stent for treating in-stent restenosis after prior stent placement.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• In-stent Restenosis

Drugs mentioned

• New Generation Drug Eluting Stent

Snippet

Sponsor: Korea University Anam Hospital | Conditions: In-stent Arterial Restenosis | Phase 4 | Status: UNKNOWN